CancerFree Biotech
PrivateLast Round
Accelerator
Jul 1, 2023
Total Funding Raised
$1.11M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
CancerFree Biotech is a biotechnology company that provides a circulating tumor cell-derived organoid platform designed to predict patient responses to cancer therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials
Business Model
B2B2C
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CancerFree Biotech Comparables
Compare CancerFree Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pear Bio | 79% | |
| OnconiX AG | 78% | |
| Orakl Oncology | 77% | |
CancerFree Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jul 1, 2023 | ||||
| Seed | Nov 8, 2022 | ||||
| Accelerator | Sep 28, 2021 | ||||
| Grant | Aug 1, 2020 |
Key People
Founding team and executive leadership
CancerFree Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Taipei City Government | Grant |
| Berkeley SkyDeck | Accelerator |
| Sustainable Impact Capital | Seed |
| Draper Associates | Seed |
| Taipei Medical University | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors increased 88% MoM, reaching 3.2K.
- Mar 1, 2026
Monthly visitors increased 67% MoM.
CancerFree Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CancerFree Biotech's valuation, stock price, and market status.